Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on September 4, 2025

ProductLife Group 擴大市場,於日本提供本地化專業知識及升級客戶支援
巴黎, Sept. 05, 2025 (GLOBE NEWSWIRE) -- ProductLife Group (PLG) 欣然宣佈在日本開設最新辦事處,此舉鞏固其致力滿足客戶需求變化及市場要求的承諾。 此擴展計劃提升營運能力,加強我們的區域及全球網絡,並推動流暢協作,以支援額外市場及服務。 隨著生命科學公司越來越需要全球專業知識及本地化人才,PLG 的發展確保客戶能夠獲享度身打造的解決方案,這有賴背後深厚的行業知識及遍佈全球的互聯團隊。 PLG 行政總裁 Xavier Duburcq …

Rapafusyn Pharmaceuticals Closes Over-Subscribed $44 Million Series A Financing to Advance Its Non-Degrading Molecular Glue Drug Discovery Platform
BioTrack Capital and Yonjin Capital join Series A round alongside other investors including 3E Bioventures Capital, Proxima Ventures Ltd., and Lapam Capital Upsized and over-subscribed Series A total funding of $44 million secured Rapafusyn’s RapaGlue™ …

Rise of Weed Pollen and Return to School Ushers in Sneezing Season
Washington, DC, Sept. 04, 2025 (GLOBE NEWSWIRE) -- If you’re sneezing this season, the reason could be a respiratory infection or weed pollen allergy. A review of pollen counts from cities across the country reveals a rise in levels of ragweed pollen as …

The Ninth Circuit Orders California to Respond concerning its Mandatory DEI Indoctrination in Continuing Medical Education Courses, According to the Association of American Physicians and Surgeons
TUCSON, Ariz., Sept. 04, 2025 (GLOBE NEWSWIRE) -- On September 2, the U.S. Court of Appeals for the Ninth Circuit ordered California to respond to a petition for rehearing challenging its diversity, equity, and inclusion (DEI) mandated inclusion in all …

NJ Healthy Aging Summit to Spotlight Opioid Safety and Alternatives for Older Adults
ATLANTIC CITY, Sept. 04, 2025 (GLOBE NEWSWIRE) -- A conference later this month will examine the keys to healthy aging and the challenges that prescribed opioids and opioid dependency pose to the older adult population. "NJ Healthy Aging Summit: Opioid …

Avania Strengthens Leadership Team with Appointment of Four New Executives
BILTHOVEN, Netherlands and BOSTON, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Avania, the leading global MedTech advisory and clinical development partner, is pleased to announce strategic leadership appointments of four distinguished executives. As the MedTech …

Oculis and EURETINA Announce the Winner of the Ramin Tadayoni Award 2025
ZUG, Switzerland, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations for ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs, today …

OPSEU/SEFPO and CUPE Ontario community and social services workers launch “Worth Fighting For” coordinated bargaining campaign at rally in Hamilton
Hamilton, Ontario, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Today, hundreds of OPSEU/SEFPO and CUPE Ontario workers and labour allies rallied in Hamilton to demand immediate, long-term funding for community and social services; affirming their commitment to …

Global Colorectal Surgical Devices Market to Advance at Moderate CAGR of ~8% by 2032 | DelveInsight
New York, USA, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Global Colorectal Surgical Devices Market to Advance at Moderate CAGR of ~8% by 2032 | DelveInsight The colorectal surgical devices market is predicted to surge owing to the rising incidence of colorectal …

Reverse Stock Split Strengthens HealthLynked’s Market Position as Company Scales AI-Driven Healthcare Platform
NAPLES, Fla., Sept. 04, 2025 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. (OTCQB: HLYK) -- Dear Shareholders, I'm writing to share an important update in the continued evolution of HealthLynked Corp. that reflects our commitment to long-term growth …

OSE Immunotherapeutics: A Clear Strategy, Balanced Governance, and a Firm Course toward Value Creation
OSE Immunotherapeutics: A Clear Strategy, Balanced Governance, and a Firm Course toward Value Creation NANTES, France – September 4, 2025, 6 p.m. CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) reaffirms its strategic commitment to value …

OSE Immunotherapeutics : une stratégie claire, une gouvernance équilibrée, un cap affirmé vers la création de valeur
OSE Immunotherapeutics : une stratégie claire, une gouvernance équilibrée, un cap affirmé vers la création de valeur NANTES, France – 4 septembre 2025, 6 p.m. CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) réaffirme, à l’approche de l’ …

Dr. Gregory Facemyer Scholarship Launches Nationwide Essay Contest for Aspiring Medical Doctors
YOUNGSTOWN, Ohio, Sept. 04, 2025 (GLOBE NEWSWIRE) -- The Dr. Gregory Facemyer Scholarship for Medical Students officially opens its application cycle, inviting undergraduate students across the United States to submit original essays that explore the …

Legend Senior Living Welcomes Annalisa Hahn as Senior Vice President of Sales and Marketing
WICHITA, Kan., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Legend Senior Living, a nationally recognized senior living provider with more than 70 residences across seven states, is pleased to announce the appointment of Annalisa Hahn as Senior Vice President of …

Bay Area Lyme Foundation Launches Bay Area Lyme Ventures as First Impact Investment Fund to Support Entrepreneurs and Companies Advancing Lyme Disease Solutions
PORTOLA VALLEY, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced the launch of Bay Area Lyme Ventures (Lyme Ventures), a bold new impact fund that is the first …

AIM ImmunoTech Highlights Growing Body of Compelling Data of Ampligen for the Treatment of Pancreatic Cancer at Conference in Poland
Latest progress from lead program Ampligen for the treatment of pancreatic cancer highlighted at the International 5th Annual Marie Skłodowska-Curie Symposium on Cancer Research and Care (MSCI MSCS-2025); Presentation now available here Ampligen has …

PridCor Therapeutics Reports Positive Long COVID Case Series with Combination Antiviral Regimen
-New Preprint: PridCor Therapeutics LLC has released a pre-print detailing a case series of 15 patients with Long COVID (LC) who were given a continuous regimen of 120-days of valacyclovir and celecoxib with a pulsed 15-day treatment of Paxlovid ( …

Really Global Launches Global Mental Health Marketplace with 2000+ Search Filters Connecting Clients to Providers in 200+ Countries
San Francisco, CA, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Really Global today announced the launch of its comprehensive mental health marketplace that connects clients with therapists, psychologists, nurse practitioners, social workers, coaches, and mentors …

The University of Alabama and GATC Health Unveil Strategic Program to Accelerate Therapeutic Discovery and Development
IRVINE, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- GATC Health Corp, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery and development, today announced the launch of a strategic program with The University of …

Cardiac Biotech Solutions, Inc. (CBSC) Signs Exclusive 5-Year Distribution Agreement with Noventis Medical Covering Costa Rica, Panama, Colombia, and Argentina
LAS VEGAS, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Cardiac Biotech Solutions, Inc. (OTCID: CBSC) ("CBSC" or the "Company"), a designer, manufacturer, and distributor of non-invasive ambulatory cardiac monitoring products, today announced the execution of a new …